• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov6
Adma Biologics released FY2025 Q3 earnings on November 5 After-Market (EST), actual revenue USD 134.22 M (forecast USD 130.53 M), actual EPS USD 0.1499 (forecast USD 0.15)
00:00
Adma Biologics released FY2025 9 Months Earnings on November 5 After-Market EST, actual revenue USD 371.01 M, actual EPS USD 0.3999
00:00
Nov5
ADMA Biologics Raises Full-Year Revenue Guidance
21:06
Oct29
Adma Biologics to release FY2025 Q3 earnings on November 5 After-Market EST, forecast revenue USD 130.53 M, EPS USD 0.15
00:06
Aug14
Nuveen LLC Purchased ADMA Biologics' New Shares in Q1
09:04
Aug6
Adma Biologics released FY2025 Q2 earnings on August 6 After-Market (EST), actual revenue USD 121.98 M (forecast USD 121.77 M), actual EPS USD 0.1399 (forecast USD 0.1366)
23:00

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 134.22 M, Net Income 36.43 M, EPS 0.1499

Aug6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 121.98 M, Net Income 34.22 M, EPS 0.1399

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 114.8 M, Net Income 26.9 M, EPS 0.11

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More